Home › Funds › Parkman Healthcare Partners LLC › SNDX
Parkman Healthcare Partners LLC position in SNDX
SYNDAX PHARMACEUTICALS INC · Health Care
Parkman Healthcare Partners LLC reported holding 1,105,057 shares of SNDX (SYNDAX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$20.8M, representing 1.88% of its reported portfolio and ranking #13 among its reported holdings. Parkman Healthcare Partners LLC has disclosed SNDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's SNDX position evolved
Parkman Healthcare Partners LLC first disclosed a stake in SNDX in Q3 2023 at 212,448 shares (US$3.1M). The position peaked in Q1 2026 at 901,511 shares, worth US$21.1M. Across 13 filings, Parkman Healthcare Partners LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,105,057 shares valued at US$20.8M — an increase of 227,801 shares quarter over quarter.. Notable position changes include a 248% increase in Q4 2023 (shares rose 10% over the following quarter), a 46% increase in Q2 2025 (shares rose 64% over the following quarter), a 57% increase in Q1 2026 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 212.45K | $3.08M | New |
| Q4 2023 | 738.59K | $15.96M | Add |
| Q1 2024 | 784.81K | $18.68M | Add |
| Q2 2024 | 600.70K | $12.33M | Reduce |
| Q3 2024 | 508.28K | $9.78M | Reduce |
| Q4 2024 | 526.97K | $6.97M | Add |
| Q1 2025 | 594.99K | $7.31M | Add |
| Q2 2025 | 867.81K | $8.13M | Add |
| Q3 2025 | 846.90K | $13.03M | Reduce |
| Q4 2025 | 574.02K | $12.06M | Reduce |
| Q1 2026 | 901.51K | $21.06M | Add |
| Q2 2026 | 877.26K | $19.18M | Reduce |
| Q3 2026 | 1.11M | $20.78M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SNDX and 13F data
SNDX (SYNDAX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in SNDX — the largest reported positions include Kynam Capital Management, LP (US$153.2M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$82.6M), Eversept Partners, LP (US$45.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SNDX
- Kynam Capital Management, LP 8.15M sh · $153.24M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.78M sh · $82.63M · Q2 2026
- Eversept Partners, LP 2.44M sh · $45.93M · Q3 2026
- Elmind Capital, LP 1.85M sh · $40.55M · Q2 2026
- Soleus Capital Management, L.P. 1.63M sh · $35.59M · Q2 2026
- ORBIMED ADVISORS LLC 1.54M sh · $33.71M · Q2 2026
- MPM BioImpact LLC 1.33M sh · $29.15M · Q2 2026
- Catalio Capital Management, LP 1.22M sh · $26.58M · Q2 2026
- Aisling Capital Management LP 1.32M sh · $24.76M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 1.01M sh · $22.18M · Q2 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held SNDX?
Parkman Healthcare Partners LLC has disclosed SNDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Parkman Healthcare Partners LLC's current position in SNDX?
As of Q3 2026, Parkman Healthcare Partners LLC holds 1.11M shares of SNDX (SYNDAX PHARMACEUTICALS INC), valued at $20.78M, representing 1.88% of its reported portfolio and ranking #13.
Has Parkman Healthcare Partners LLC been buying or selling SNDX?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC increased its position in SNDX. The position peaked in Q1 2026 at 901.51K shares.
Which other funds hold SNDX?
Other major institutional holders of SNDX include Kynam Capital Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P., Eversept Partners, LP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.